Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2025-12-24 @ 7:16 PM
NCT ID:
NCT07037303
Eligibility Criteria:
Inclusion Criteria:
* 18 years of age or older
* Patients diagnosed with bronchiectasis involving one or more lobes on chest computed tomography (CT)
* Patients experiencing frequent exacerbations (3 or more exacerbations) within 1 year
* Patients able and willing to use the Aerobika device (OPEP)
Exclusion Criteria:
* Diagnosis of bronchiectasis due to cystic fibrosis
* Traction bronchiectasis due to interstitial lung disease (ILD)
* Pregnant patients
* Patients with a history of OPEP device use
* Patients who cannot tolerate increased breathing work
* Hemodynamic instability (e.g., unstable blood pressure)
* Patients with a past or current history of hemoptysis (pulmonary bleeding) and untreated pneumothorax
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07037303
Study Brief:
Protocol Section:
NCT07037303